Remission Phase in Paediatric Type 1 Diabetes: New Understanding and Emerging Biomarkers

A divergent population of autoantigen-responsive CD4 + T cells in infants prior to β cell autoimmunity

(2017) Anne-Kristin Heninger et al.   Science Translational Medicine

A pilot study showing associations between frequency of CD4+ memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes

(2016) Rosita Moya et al.   CLINICAL IMMUNOLOGY

Longitudinal Evaluation of Cognitive Functioning in Young Children with Type 1 Diabetes over 18 Months

(2016) M. Allison Cato et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose-adjusted HbA1c in 3657 children and adolescents from Germany and Austria

(2016) Katrin Nagl et al.   PEDIATRIC DIABETES

Effect of autoimmunity risk loci on the honeymoon phase in type 1 diabetes

(2016) Mandana Moosavi et al.   PEDIATRIC DIABETES

Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes

(2016) Renecia A. Watkins et al.   Translational Research

Immunotherapies and immune biomarkers in Type 1 diabetes: A partnership for success

(2015) Niels V. Rekers et al.   CLINICAL IMMUNOLOGY

Function of Isolated Pancreatic Islets From Patients at Onset of Type 1 Diabetes: Insulin Secretion Can Be Restored After Some Days in a Nondiabetogenic Environment In Vitro

(2015) Lars Krogvold et al.   DIABETES

Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association

(2015) Richard A. Insel et al.   DIABETES CARE

Human autoimmune diseases: a comprehensive update

(2015) Lifeng Wang et al.   JOURNAL OF INTERNAL MEDICINE

Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes

(2015) Majid Jaberi-Douraki et al.   JOURNAL OF THEORETICAL BIOLOGY

Role of Viruses and Other Microbes in the Pathogenesis of Type 1 Diabetes

(2014) Anita Kondrashova et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Phases of type 1 diabetes in children and adolescents

(2014) Jennifer J Couper et al.   PEDIATRIC DIABETES

Partial Remission Definition: Validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish Children with New-Onset Type 1 Diabetes

(2014) Marie Louise C Max Andersen et al.   PEDIATRIC DIABETES

Maternal Microchimerism: Increased in the Insulin Positive Compartment of Type 1 Diabetes Pancreas but Not in Infiltrating Immune Cells or Replicating Islet Cells

(2014) Jody Ye et al.   PLoS One

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment

(2013) Tihamer Orban et al.   DIABETES CARE

The clinical utility of C-peptide measurement in the care of patients with diabetes

(2013) A. G. Jones et al.   DIABETIC MEDICINE

Efferocytosis Promotes Suppressive Effects on Dendritic Cells through Prostaglandin E2 Production in the Context of Autoimmunity

(2013) Irma Pujol-Autonell et al.   PLoS One

Clinical Immunologic Interventions for the Treatment of Type 1 Diabetes

(2013) L. Chatenoud et al.   Cold Spring Harbor Perspectives in Medicine

Diabetic Ketoacidosis at Diagnosis Influences Complete Remission After Treatment With Hematopoietic Stem Cell Transplantation in Adolescents With Type 1 Diabetes

(2012) W. Gu et al.   DIABETES CARE

Insulin-dose-adjusted HbA1c-defined partial remission phase in a paediatric population-when is the honeymoon over?

(2012) O. M. Neylon et al.   DIABETIC MEDICINE

Trends in childhood type 1 diabetes incidence in Europe during 1989–2008: evidence of non-uniformity over time in rates of increase

(2012) C. C. Patterson et al.   DIABETOLOGIA

The Epidemiology of Type 1 Diabetes in Children

(2012) Diana E. Stanescu et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Insulin Pump Therapy Started at the Time of Diagnosis: Effects on Glycemic Control and Pancreatic β-Cell Function in Type 1 Diabetes

(2011) Kathryn M. Thrailkill et al.   Diabetes Technology & Therapeutics

Early Markers of Glycaemic Control in Children with Type 1 Diabetes Mellitus

(2011) Samuel W. Cutfield et al.   PLoS One

The honeymoon phase: intersection of metabolism and immunology

(2011) Hanan Aly et al.   Current Opinion in Endocrinology Diabetes and Obesity

Diet with a low n-6/n-3 essential fatty acid ratio when started immediately after the onset of overt diabetes prolongs survival of type 1 diabetes model NOD mice

(2010) Yukiko Kagohashi et al.   CONGENITAL ANOMALIES

Gene expression profiles for the human pancreas and purified islets in Type 1 diabetes: new findings at clinical onset and in long-standing diabetes

(2009) R. Planas et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes

(2009) H. B. Mortensen et al.   DIABETES CARE

Challenges in developing endpoints for type 1 diabetes intervention studies

(2009) Simona Cernea et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis

(2009) Henrik B Mortensen et al.   PEDIATRIC DIABETES

Islet antigen specific IL-10+ immune responses but not CD4+CD25+FoxP3+ cells at diagnosis predict glycemic control in type 1 diabetes

(2008) Srinath Sanda et al.   CLINICAL IMMUNOLOGY

Phenotype and function of human T lymphocyte subsets: Consensus and issues

(2008) Victor Appay et al.   CYTOMETRY PART A

 -Cell Mass and Type 1 Diabetes: Going, Going, Gone?

(2008) E. Akirav et al.   DIABETES